Transient fluorodeoxyglucose-avid hepatic foci after biliary stenting as a diagnostic pitfall in ampullary adenocarcinoma: A case report and review of literature
Year: 2026
Type: article
Study design: Case Report
Abstract: BACKGROUNDDistant metastasis precludes curative resection in ampullary adenocarcinoma.As 18 Ffluorodeoxyglucose uptake is not tumor specific, hepatic inflammation after biliary instrumentation may create a consequential staging pitfall. CASE SUMMARYA 61-year-old man presented with painless jaundice and pruritus and underwent biliary stenting for an obstructing ampullary lesion after three nondiagnostic preoperative sampling procedures.Recurrent fever and elevated inflammatory markers followed stenting.18 F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) detected three hepatic foci suspicious of metastases without definite liver magnetic resonance imaging correlates, and the foci could not be reliably targeted for biopsy.Multidisciplinary review prompted repeat PET/CT, which showed complete metabolic resolution during antimicrobial treatment before antitumor therapy, supporting a presumed inflammatory or infectious process without establishing its etiology.Pancreaticoduodenectomy confirmed pancreatobiliary-type ampullary adenocarcinoma, pT3bN0.At the last visit nine months postoperatively, the patient was clinically stable; the latest imaging was three months after surgery. CONCLUSIONDiscordant post-stenting hepatic 18 F-FDG uptake warrants multidisciplinary reassessment before metastasis is assigned when biopsy is infeasible.
DOI: 10.4240/wjgs.127478
Language: English
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7236289327
